Search results for “Tumor Syndrome” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 209 patents, we discovered top 23 key players by total patent application. Wellstat Therapeutics Corp., Teijin Pharma Ltd., Signal Pharmaceuticals LLC are dominant in this area. They take 59.33% of the total patent filing.
Wellstat Therapeutics Corp.
United States
Patent: 45
Teijin Pharma Ltd.
Tokyo-to, Japan
Patent: 45
Signal Pharmaceuticals LLC
California, United States
Patent: 34
Teijin Ltd.
Tokyo-to, Japan
Patent: 19
MorphoSys AG
Bayern, Germany
Patent: 10
Italfarmaco SpA
Lombardia, Italy
Patent: 9
The General Hospital Corp.
Massachusetts, United States
Patent: 7
AZTherapies, Inc.
Massachusetts, United States
Patent: 6
The Georgia Tech Research Corp.
Georgia, United States
Patent: 3
Inotek Pharmaceuticals Corp.
Massachusetts, United States
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 2 patents, we discovered top 1 start-ups by total patent application.
STARTUP
SeaStar Medical, Inc.
Colorado, United States
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 40 patents applied in the last 5 years. We discover 12 most active companies in this area. The fast-growing MorphoSys AG, Dana-Farber Cancer Institute, Inc., The General Hospital Corp. take 62.50% of patent filing during this period.
MorphoSys AG
Bayern, Germany
Patent: 10
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 8
The General Hospital Corp.
Massachusetts, United States
Patent: 7
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 6
AZTherapies, Inc.
Massachusetts, United States
Patent: 6
Teijin Pharma Ltd.
Tokyo-to, Japan
Patent: 2
STARTUP
SeaStar Medical, Inc.
Colorado, United States
Patent: 2
Tolero Pharmaceuticals, Inc.
Utah, United States
Patent: 1
Guizhou Ankang Clinical Laboratories, Inc.
Guizhou Sheng, China
Patent: 1
Sumitomo Pharma Oncology, Inc.
Massachusetts, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 40 patents in last 5 years, we discover 9 new entrants. MorphoSys AG, The General Hospital Corp., Ruprecht-Karls-Universität Heidelberg are the most active new entrants in this area.
MorphoSys AG
Bayern, Germany
Patent: 10
The General Hospital Corp.
Massachusetts, United States
Patent: 7
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 6
AZTherapies, Inc.
Massachusetts, United States
Patent: 6
STARTUP
SeaStar Medical, Inc.
Colorado, United States
Patent: 2
Tolero Pharmaceuticals, Inc.
Utah, United States
Patent: 1
Guizhou Ankang Clinical Laboratories, Inc.
Guizhou Sheng, China
Patent: 1
Sumitomo Pharma Oncology, Inc.
Massachusetts, United States
Patent: 1
Georgia State University Research Foundation, Inc.
Georgia, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 12 patents, we discovered top 4 universities and scientific research institutions by total patent application. Ruprecht-Karls-Universität Heidelberg, Duke University, University of Medicine & Dentistry of New Jersey are dominant in this area. They take 83.33% of the total patent filing.
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 6
Duke University
North Carolina, United States
Patent: 2
University of Medicine & Dentistry of New Jersey
New Jersey, United States
Patent: 1
University of Fukui
Fukui-ken, Japan
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: